BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7914071)

  • 1. EP1-receptor mediation of prostaglandin E2-induced hyperthermia in rats.
    Oka T; Hori T
    Am J Physiol; 1994 Jul; 267(1 Pt 2):R289-94. PubMed ID: 7914071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 may induce hyperthermia through EP1 receptor in the anterior wall of the third ventricle and neighboring preoptic regions.
    Oka K; Oka T; Hori T
    Brain Res; 1997 Aug; 767(1):92-9. PubMed ID: 9365020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of plasma noradrenaline levels in urethane-anaesthetized rats by activation of central prostanoid EP3 receptors.
    Yokotani K; Nishihara M; Murakami Y; Hasegawa T; Okuma Y; Osumi Y
    Br J Pharmacol; 1995 Jun; 115(4):672-6. PubMed ID: 7582489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebroventricular injection of prostaglandin E2 induces thermal hyperalgesia in rats: the possible involvement of EP3 receptors.
    Oka T; Aou S; Hori T
    Brain Res; 1994 Nov; 663(2):287-92. PubMed ID: 7874513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKL.
    Tsujisawa T; Inoue H; Nishihara T
    J Bone Miner Res; 2005 Jan; 20(1):15-22. PubMed ID: 15619665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGE2 receptor subtype EP1 antagonist may inhibit central interleukin-1beta-induced fever in rats.
    Oka K; Oka T; Hori T
    Am J Physiol; 1998 Dec; 275(6):R1762-5. PubMed ID: 9843865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor.
    Zeng L; An S; Goetzl EJ
    Biochemistry; 1996 Jun; 35(22):7159-64. PubMed ID: 8679543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebroventricular injection of prostaglandin E2 increases splenic sympathetic nerve activity in rats.
    Ando T; Ichijo T; Katafuchi T; Hori T
    Am J Physiol; 1995 Sep; 269(3 Pt 2):R662-8. PubMed ID: 7573569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biphasic modulation in the trigeminal nociceptive neuronal responses by the intracerebroventricular prostaglandin E2 may be mediated through different EP receptors subtypes in rats.
    Oka T; Hori T; Hosoi M; Oka K; Abe M; Kubo C
    Brain Res; 1997 Oct; 771(2):278-84. PubMed ID: 9401748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of the central prostaglandin EP3 receptors in cardiovascular regulation in rats.
    Ariumi H; Takano Y; Masumi A; Takahashi S; Hirabara Y; Honda K; Saito R; Kamiya HO
    Neurosci Lett; 2002 May; 324(1):61-4. PubMed ID: 11983295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats.
    Tang EH; Jensen BL; Skott O; Leung GP; Feletou M; Man RY; Vanhoutte PM
    Cardiovasc Res; 2008 Apr; 78(1):130-8. PubMed ID: 18093985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EP1 receptor blockade attenuates both spontaneous tone and PGE2-elicited contraction in guinea pig trachealis.
    Ndukwu IM; White SR; Leff AR; Mitchell RW
    Am J Physiol; 1997 Sep; 273(3 Pt 1):L626-33. PubMed ID: 9316498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor subtypes involved in dual effects induced by prostaglandin E2 in circular smooth muscle from dog colon.
    Botella A; Delvaux M; Fioramonti J; Frexinos J; Bueno L
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1008-14. PubMed ID: 7791070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulatory (EP1 and EP3) and inhibitory (EP2) prostaglandin E2 receptors in isolated ileal smooth muscle cells.
    Botella A; Delvaux M; Fioramonti J; Frexinos J; Bueno L
    Eur J Pharmacol; 1993 Jun; 237(1):131-7. PubMed ID: 7689467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human granulosa-lutein cells express functional EP1 and EP2 prostaglandin receptors.
    Harris TE; Squires PE; Michael AE; Bernal AL; Abayasekara DR
    Biochem Biophys Res Commun; 2001 Aug; 285(5):1089-94. PubMed ID: 11478765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery.
    Qian YM; Jones RL; Chan KM; Stock AI; Ho JK
    Br J Pharmacol; 1994 Oct; 113(2):369-74. PubMed ID: 7834185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prostaglandin E series modulates high-voltage-activated calcium channels probably through the EP3 receptor in rat paratracheal ganglia.
    Ito Y; Murai Y; Ishibashi H; Onoue H; Akaike N
    Neuropharmacology; 2000 Jan; 39(2):181-90. PubMed ID: 10670413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice.
    Minami T; Nishihara I; Uda R; Ito S; Hyodo M; Hayaishi O
    Br J Pharmacol; 1994 Jul; 112(3):735-40. PubMed ID: 7921597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
    Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
    Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.